The gut microbiome in Parkinson's disease: a longitudinal study of the impacts on disease progression and the use of device-assisted therapies
Neuroprotective Studies MC1R activation influences AMPK, SIRT1, and PGC-1 pathways that regulate mitochondrial metabolism
AlphaScreen cAMP assay system 5
Tres efficace et nergisant
With oral GLP-1 options expected to arrive next year , the GLP-1 market will become even more competitive, raising consumer expectations for both cost and convenience
FDA-approved branded medications through telehealth platforms with a membership-plus-medication model add a $39$149/month membership fee on top of the medication itself, with Wegovy or Zepbound retail running roughly $1,000$1,349/month before insurance though Lilly Direct's self-pay Zepbound vials brought the branded tirzepatide cash-pay price down to ~$499/month for eligible patients in 2026